Replies to post #290711 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

The one new thing that might point to a merger or partnership in this context of the German tax is that hidden details like this usually come up when the due diligence team comes in and looks through everything, looking for issues like this before they finalize a deal.

So, this may have come out of due diligence and they may want to resolve it fully before they make their filing to exclude it from any discussion.

[Poor Man -]

Just to put a positive spin on the tax matter, selling the company’s assets or shares could trigger certain tax obligations for capital gains and fall within the scope of VAT rules even if the sale is by a non-resident corporation with a percentage of its investment in Germany.

There are all kind of tax considerations in a sale of company assets or shares. Not sure whether or why that would have any barring on the release of the 10QK, but just a thought.